NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Watershed Therapeutics

Watershed Therapeutics

Private
Los Altos, CaliforniaHealthcare & Life Scienceshttps://www.watershedtx.com/

Last Round

Seed Round

Apr 14, 2026

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Watershed Therapeutics is a drug delivery company that develops a targeted technology for delivering long-term therapies directly to the bladder for conditions like bladder cancer and recurrent urinary tract infections.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

bladder drug deliverydrug delivery platformlocalized drug deliverysustained drug deliverymedtechdrug delivery deviceurologyrecurrent UTIfloating therapyurinary tract infectionbladder canceroveractive bladder

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Watershed Therapeutics Comparables

Compare Watershed Therapeutics with similar companies based on industry and business-model similarity.

Watershed Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Watershed Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundApr 14, 2026
SeedApr 19, 2023
AcceleratorSep 6, 2022
SeedAug 1, 2022

Key People

Founding team and executive leadership

Saniya Ali

Cofounder Chief Technology Officer

Founding Team

Topher Kinsella

Co-Founder, CEO

Founding Team

Watershed Therapeutics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 2, 2026

    Grew 38% QoQ from 8 to 11 employees.

  • May 20, 2026

    Monthly visitors increased 77% MoM.

Watershed Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Watershed Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Watershed Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersLos Altos, California
Employee Range10
Year Founded2019
Last FundingApr 14, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.